Kyverna Therapeutics Inc

KYTX NASDAQ Santé & Biotech États-Unis
7.95 $
1.66 %

Kyverna Therapeutics Inc est une entreprise biopharmaceutique axée sur le développement de thérapies cellulaires pour le traitement des maladies auto-immunes et inflammatoires.

Performance & Momentum

6 Months
1 Year
3 Years
5 Years 73.59 %

Similar stocks to Kyverna Therapeutics Inc

Anantys Community

Be the first to share your analysis on Kyverna Therapeutics Inc.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases